Abstract
Aim This study investigates factors influencing pandemic mortality rates across U.S. states during different waves of SARS-CoV-2 infection from February 2020 to April 2023, given that over one million people died from COVID-19 in the country.
Methods We performed statistical analyses and used linear regression models to estimate age-adjusted and unadjusted excess mortality as functions of life expectancy, vaccination rates, and GDP per capita in U.S. states.
Results and Discussion States with lower life expectancy and lower GDP per capita experienced significantly higher mortality rates during the pandemic, underscoring the critical role of underlying health conditions and healthcare infrastructure, as reflected in these factors. When categorizing states by vaccination rates, significant differences in GDP per capita and pre-pandemic life expectancy emerged between states with lower and higher vaccination rates, likely explaining mortality disparities before mass vaccination. During the Delta and Omicron BA.1 waves, when vaccines were widely available, the mortality gap widened, and states with lower vaccination rates experienced nearly double the mortality compared to states with higher vaccination rates (Odds Ratio 1.8, 95% CI 1.7-1.9, p < 0.01). This disparity disappeared during the later Omicron variants, likely because the levels of combined immunity from vaccination and widespread infection across state populations became comparable. We showed that vaccination rates were the only significant factor influencing age-adjusted mortality, highlighting the substantial impact of age-specific demographics on both life expectancy and GDP across states.
Conclusion The study underscores the critical role of high vaccination rates in reducing excess deaths across all states, regardless of economic status. Vaccination rates proved more decisive than GDP per capita in reducing excess deaths. Additionally, states with lower pre-pandemic life expectancy faced greater challenges, reflecting the combined effects of healthcare quality, demographic variations, and social determinants of health. These findings call for comprehensive public health strategies that address both immediate interventions, like vaccination, and long-term improvements in healthcare infrastructure and social conditions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Intramural Research Program of the National Library of Medicine, National Institutes of Health (AYO and SAS).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
The revised manuscript broadens the scope of the study by incorporating a more comprehensive analysis of factors influencing pandemic mortality rates across U.S. states. In addition to analyzing unadjusted excess mortality, we now introduce age-adjusted mortality. The revised text also includes an analysis of the impact of life expectancy on both age-adjusted and unadjusted excess mortality.
Data Availability
Our work was performed with publicly available datasets. All data generated or analyzed during this study is provided as supplementary information files.
